We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

86 hedge funds and large institutions have $131M invested in Cascadian Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $2.1M | Put options by funds: $686K

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

20% more capital invested

Capital invested by funds: $110M → $131M (+$21.7M)

16% more funds holding

Funds holding: 74 → 86 (+12)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 26

Holders
86
Holders Change
+12
Holders Change %
+16.22%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
26
Reduced
26
Closed
6
Calls
$2.1M
Puts
$686K
Net Calls
+$1.42M
Net Calls Change
-$124K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$4.59M
2
BI
BVF Inc
California
+$2.52M
3
State Street
State Street
Massachusetts
+$1.85M
4
BIT
BlackRock Institutional Trust
California
+$1.85M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$782K

Top Sellers

Rank Fund Capital Flow
1
First Eagle Investment Management
First Eagle Investment Management
New York
-$1M
2
PA
Perceptive Advisors
New York
-$736K
3
CS
Credit Suisse
Switzerland
-$710K
4
GPP
Great Point Partners
Connecticut
-$588K
5
U
UBS
Switzerland
-$520K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$644K +$282K +15,970 +93%
Allianz Asset Management
27
Allianz Asset Management
Germany
$588K -$55.1K -3,125 -9%
Northern Trust
28
Northern Trust
Illinois
$584K +$222K +12,604 +72%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$541K +$350K +19,866 +249%
Morgan Stanley
30
Morgan Stanley
New York
$519K -$476K -27,008 -50%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$502K -$398K -22,582 -47%
Charles Schwab
32
Charles Schwab
California
$420K +$305K +17,300 +404%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$419K +$380K +21,533 New
WMSA
34
Weiss Multi-Strategy Advisers
New York
$324K – – –
TA
35
Teachers Advisors
New York
$318K +$289K +16,360 New
SG Americas Securities
36
SG Americas Securities
New York
$316K +$287K +16,253 New
ARTA
37
A.R.T. Advisors
New York
$257K +$87.4K +4,955 +60%
Nomura Holdings
38
Nomura Holdings
Japan
$230K +$15.8K +897 +8%
VOYA Investment Management
39
VOYA Investment Management
Georgia
$198K +$179K +10,174 New
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$189K +$171K +9,720 New
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$176K +$160K +9,068 New
NFA
42
Nationwide Fund Advisors
Ohio
$171K +$155K +8,801 New
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$162K +$139K +7,901 +1,904%
CS
44
Credit Suisse
Switzerland
$156K -$710K -40,265 -83%
BA
45
BlackRock Advisors
Delaware
$155K +$94.5K +5,355 +206%
LTFS
46
Ladenburg Thalmann Financial Services
Florida
$154K +$18K +1,022 +15%
Group One Trading
47
Group One Trading
Illinois
$153K +$73.8K +4,182 +114%
AIG
48
American International Group
New York
$150K +$136K +7,713 New
ProShare Advisors
49
ProShare Advisors
Maryland
$112K +$101K +5,746 New
Citigroup
50
Citigroup
New York
$106K -$3.93K -223 -4%
1
2
3 4

CASC Hedge Fund Activity: Q2 2014 in Review

86 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q2 2014, worth a combined $131M — up 20% from $110M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CASC positions and 6 closed out — a net gain of 12 holders — while 26 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $4.59M. The largest seller was First Eagle Investment Management, cutting an estimated $1M.

  • 86 institutional investors held Cascadian Therapeutics, Inc. (CASC) as of Q2 2014, up from 74 in Q1 2014.
  • Funds reported $131M of Cascadian Therapeutics, Inc. stock for Q2 2014, up 20% quarter-over-quarter.
  • 18 funds opened new Cascadian Therapeutics, Inc. positions in Q2 2014 and 6 closed out, a net change of +12 holders.
  • The largest Cascadian Therapeutics, Inc. buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $4.59M added.
  • The largest Cascadian Therapeutics, Inc. seller in Q2 2014 was First Eagle Investment Management, an estimated $1M sold.

Based on aggregated 13F filings for Q2 2014.